Connect with us

General News

Is Extracting Medical Cannabis Challenging?

Published

on

In the market, only a handful of companies are now integrating innovative technologies to extract medical cannabis. These technologies come up with high efficiency for operations at a smaller level that cannot develop the infrastructure themselves.

Medical cannabis extraction is of paramount importance in the whole process of medical cannabis production. The process can be challenging as engineers haven’t designed an equipment specifically for the cannabis extraction yet. Consequently, the yield is not at its optimum level.

Challenges for innovation in cannabis extraction

GMP (Good Manufacture Practices) certification is a standard to approve any industrial equipment and procedure. Currently, companies concerning the extraction have a tough time getting the GMP certification.

Some companies had applied for the certification for over a year but got no approval. However, different methods to extract medical cannabis are available which will not get a certification of GMP. Therefore, it is vital as a company to invest in the tools and devices that would be beneficial for the company.

The GMP will consider those techniques and equipment fit for approval that integrate the latest tech and depict specification.

Future of medical cannabis production

Medical cannabis products will be the deciding factor in the evolution of the extraction process. The carbon dioxide extraction method is among the popular methods to extract medical cannabis nowadays. It is because the extraction process does not need any bomb-proof amenities and is the method with no by-products.

Some companies are beginning to explore extraction methods of ethanol and hydrocarbon through butane and propane. Although these methods would need a bombproof material, the opportunity is considerable.

US and Canada realize that it can be challenging for organizations to develop a convenient infrastructure for extraction. Therefore, private medical cannabis extraction companies are advantageous for the emerging industry.

Europe, however, is deficient in creating innovative products. Mostly the products are dried cannabis or capsules. There is fundamentally no development in topical lotions, sublingual and transdermal products. It is something Europe will have to consider and learn from North America to get a good share in the global market.

What does the cannabis production market demand?

Medical cannabis will have the lion’s share in the contribution of cannabis market growth. The United States of America has had a fair deal of dedicated researchers and engineers for the matter. Canada is already joining hands with the US in the cause.

Anyhow, there are also high hopes from Europe in the market. With a population of 700 million people, the global medical cannabis market alone can make till around 200 billion USD.

After a decade or two, the shape of the global cannabis market will change entirely. Europe will also play a huge role in it along with North America and Israel.

However, research profiles are considerably low, and they need to speed up to better support the positive forecasts. The future of the market seems to be positive with the advent of more interest growing in the industry. However, there is a dire need to integrate the latest technologies that are solely specified for cannabis extraction.

 

 

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

General News

Global Alliance for Cannabis Commerce announces GACC Certified™ testing

Published

on

The Global Alliance for Cannabis Commerce (GACC) provides policymakers and legislators with the guidance necessary to take the nascent cannabis industry from the gray market into a global provider of medical and adult-use cannabis products.

Recently, the Company announced the launch of a nationwide, voluntary industry certification standard for safety and purity in cannabis product testing. The aim of this program is to provide licensed sellers and consumer confidence that the legal products are safe and they meet the purity standards. By the end of 2020, this program will be available to all state-licensed cannabis operations.

The Executive Director at GACC, Randal John Meyer says that with the current laws it is impossible to make sure that there are uniform standards for purity. Furthermore, GACC President Rezwan Khan added, ”GACC wants to establish a means by which consumers can have confidence in the products they buy and to provide the industry the tools to give this assurance.”

GACC and the member of the companies believe in establishing standards for safety and purity, and in creating a serious and effective testing program. Nominations for membership on the Standards Committee (terms are two years) will be open to the public beginning on Thursday, December 5, 2019, and closing on January 30, 2020.

The Board of GACC will determine the initial composition. Future members will include public nominations and will be determined by the GACCAST Standards Committee and reviewed by the GACC Board of Directors. It is expected that the GACCAST Standards Committee will take approximately nine months to establish the initial standards and protocols so that implementation can begin in 2020.

Brands such as Raw Garden, DNA Genetics, Crockett Family Farms, Urbn Leaf, La Familia, and Team Elite Genetics, and all derivative cannabis products from DNA Genetics’ and Crockett Family Farms’ genetic have pledged to support the development of the standards setting protocol and to adopt and implement it as well when it is effective.

To accommodate the entire legal cannabis industry’s access to this program, GACC will be creating a membership class, the Standard Membership, which involves minimal costs for participation, and that will provide access to the GACC Certified™ Program. GACC is also planning to arrange for testing discounts for members who use the GACC network of laboratories. The GACC President Rezwan Khan added, “Our goal is to ensure this program isn’t cost-prohibitive for any cannabis companies of any size.”

Solo sciences will be offering GACC members a substantial discount on anti-counterfeiting, instant product recall solo*CODE™ technology as they have previously partnered with GACC to ensure that medical patients and adult consumers do not unwittingly purchase counterfeit or illicit vape products.

On this account, the Executive Director of GACC added, “The combination of the voluntary GACC Certified™ consumer safety standard, particularly when combined with members’ access to substantially discounted solo*CODE™ anticounterfeiting technology, allows GACC members to provide their consumers with the confidence they need that anywhere in the United States they legally purchase a participating cannabis product, our blue leaf means it’s safe and genuine.”

Continue Reading

General News

Pasha Brand’s Board Restructuring, announces resignations

Published

on

Pasha Brands Ltd. is one of North America’s largest network and aggregator of craft cannabis. Recently, the Company announced the following resignations: Scott WaltersRosy Mondin and Hugo Alves as directors of the Company. Pasha Brand thanked them for their contributions, time, and efforts.

The Executive Chairman, Patrick Brauckmann stated, ”I’m grateful Scott, Rosy and Hugo shared my vision and were able to contribute to our unique offering. Their resignations will not diminish our resolve to see this project completed, as thousands of cannabis professionals wait in line to re-enter the industry they created.”
However, the resignations are effective immediately.

The Company is now working on establishing a new working board. The idea behind a new board is to solely include people who invested in the brand and its future. The Company’s vision includes giving opportunities for small farmers, legacy brands, the brands excluded by the government, and the founders of Canada’s original cannabis industry. This will help the companies to enter the business world through Pasha’s craft aggregation platform.

Pasha Brand as a Company has proven its capabilities in cannabis cultivation, genetic research and development, product processing, and retail. This makes the Company uniquely positioned in the new legal cannabis market through its network of hundreds of craft cannabis suppliers. Given the opportunity, the brand also plans on refreshing the ranks and reposition the key personnel to reflect the Company’s goal of having Grizzlers™ and Roll Model™ pre-rolls in the market in early 2020.

The Company has many accomplishments under its brand name. Pasha Brand has acquired 8 pre-legalization brands. It established BC Craft Supply Co, which is a solution provider to the micro cultivation community is Canada. It acquired Medcann Health Products Ltd. The Medcann Health Company is a  Health Canada licensed cultivator and processor operating out of a 10,000 square foot facility on Vancouver Island. Another one of the acquired brands is Royal Green Acres Ltd., which is a late stage licensed producer applicant under the ACMPR. The Company established a proprietory platform bringing quality assurance to the craft industry by the name of Craft Labs™.

The Pasha Brand’s common shares trade on the CSE under the symbol “CRFT” and on the FSE under the symbol “ZZD”. Commenting on these changed, the Executive Chairman, Patrick Brauckmann mentioned that he wants a Company that works on the principle of quality and meaning. The Company recruited a strong group of cannabis professionals, brokers and operators, many of who played a part in creating Canada’s original cannabis industry to continue living up to its standards.

Continue Reading

Cannabis

HempMeds® announces partnership with Sezzle, Offers New Payment Solution

Published

on

Medical Marijuana, Inc, the first company to receive historic import permits for CBD products from the governments of BrazilMexicoArgentina, and Paraguay has recently announced a partnership of its subsidiary HempMeds with Sezzel, a leading alternative digital payment platform.

Located in U.S, the first ever publicly traded cannabis company Medical Marijuana inc. has also recently launched a new line of cannabis-derived nutraceutical products, brands and supply chain. As its subsidiary, HempMeds is a corporate portfolio company which is also the Company’s master distributor and contracted marketing company, handling sales and distribution.

Sezzle, a leading alternative digital payment platform offers customers cutting-edge payment alternatives. HempMeds® customers can choose Sezzle at checkout to delay full payment for their items, at zero percent interest. Consumers receive their items right away and Sezzle pays merchant upfront and assumes all repayment risk. It requires a 25 percent down payment at the time of purchase and the remaining balance is automatically scheduled as three equal-installment payments to be paid every two weeks.

President Todd Morrow of HempMeds said that their aim is to provide better services so everyone with a tight budget can afford the benefits. Sezzle offers a “buy-now, pay-later” service that does not require shoppers to enter into a traditional loan or pay any upfront fees or interest. Sezzle is certified up to PCI DSS Level 1 as a Service Provider. He further stated, “Partnering with Sezzle means that we can provide our customers with an easy way to lift some of the financial burden during this expensive time of year.”

HempMeds® was the first company to ever bring hemp-based cannabidiol (CBD) oil products to market in the U.S. and was also the first to make CBD products available in bulk for U.S. consumers. It was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations, as well as the first to have its CBD products listed in the Prescribers’ Digital Reference and one of the first to be certified by the U.S. Hemp Authority.

Medical Marijuana, Inc. CEO Dr. Stuart Titus mentioned, “With the number of new consumers becoming interested in purchasing CBD, we believe that Sezzle is a great opportunity to make our CBD products more accessible to people of all socioeconomic backgrounds.” The number of people searching for e-commerce outlets to purchase CBD has increased every year since 2017. Researchers found that online search volume for CBD in the U.S. increased 160.4 percent in 2018 compared with 2017 and is expected to increase by 117.7 percent in 2019 compared to 2018.

Continue Reading

Trending